Literature DB >> 25449262

Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.

Gulzar Ahmad1, Bhopal C Mohapatra2, Nancy A Schulte3, Scott A Nadeau4, Haitao Luan4, Neha Zutshi5, Eric Tom2, Cesar Ortega-Cava1, Chun Tu1, Masashi Sanada6, Seishi Ogawa6, Myron L Toews3, Vimla Band7, Hamid Band8.   

Abstract

Members of the casitas B-lineage lymphoma (Cbl) family (Cbl, Cbl-b and Cbl-c) of ubiquitin ligases serve as negative regulators of receptor tyrosine kinases (RTKs). An essential role of Cbl-family protein-dependent ubiquitination for efficient ligand-induced lysosomal targeting and degradation is now well-accepted. However, a more proximal role of Cbl and Cbl-b as adapters for CIN85-endophilin recruitment to mediate ligand-induced initial internalization of RTKs is supported by some studies but refuted by others. Overexpression and/or incomplete depletion of Cbl proteins in these studies is likely to have contributed to this dichotomy. To address the role of endogenous Cbl and Cbl-b in the internalization step of RTK endocytic traffic, we established Cbl/Cbl-b double-knockout (DKO) mouse embryonic fibroblasts (MEFs) and demonstrated that these cells lack the expression of both Cbl-family members as well as endophilin A, while they express CIN85. We show that ligand-induced ubiquitination of EGFR, as a prototype RTK, was abolished in DKO MEFs, and EGFR degradation was delayed. These traits were reversed by ectopic human Cbl expression. EGFR endocytosis, assessed using the internalization of (125)I-labeled or fluorescent EGF, or of EGFR itself, was largely retained in Cbl/Cbl-b DKO compared to wild type MEFs. EGFR internalization was also largely intact in Cbl/Cbl-b depleted MCF-10A human mammary epithelial cell line. Inducible shRNA-mediated knockdown of CIN85 in wild type or Cbl/Cbl-b DKO MEFs had no impact on EGFR internalization. Our findings, establish that, at physiological expression levels, Cbl, Cbl-b and CIN85 are largely dispensable for EGFR internalization. Our results support the model that Cbl-CIN85-endophilin complex is not required for efficient internalization of EGFR, a prototype RTK.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CIN85; Cbl; Epidermal growth factor receptor; Internalization; Mouse embryonic fibroblast

Mesh:

Substances:

Year:  2014        PMID: 25449262      PMCID: PMC4268055          DOI: 10.1016/j.biocel.2014.10.019

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  53 in total

1.  The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.

Authors:  C A Joazeiro; S S Wing; H Huang; J D Leverson; T Hunter; Y C Liu
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

2.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice.

Authors:  M Naramura; H K Kole; R J Hu; H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  cbl-3: a new mammalian cbl family protein.

Authors:  M M Keane; S A Ettenberg; M M Nau; P Banerjee; M Cuello; J Penninger; S Lipkowitz
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

4.  Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain.

Authors:  S Miyake; K P Mullane-Robinson; N L Lill; P Douillard; H Band
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

5.  Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.

Authors:  W Meng; S Sawasdikosol; S J Burakoff; M J Eck
Journal:  Nature       Date:  1999-03-04       Impact factor: 49.962

6.  Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor.

Authors:  R Govers; T ten Broeke; P van Kerkhof; A L Schwartz; G J Strous
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

7.  The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha.

Authors:  S Miyake; M L Lupher; B Druker; H Band
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

8.  Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.

Authors:  Karen M Kassel; Nancy A Schulte; Stacey M Parker; Aaron D Lanik; Myron L Toews
Journal:  J Pharmacol Exp Ther       Date:  2007-07-19       Impact factor: 4.030

9.  Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.

Authors:  Alagarsamy Lakku Reddi; GuoGuang Ying; Lei Duan; Gengsheng Chen; Manjari Dimri; Patrice Douillard; Brian J Druker; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  J Biol Chem       Date:  2007-07-09       Impact factor: 5.157

Review 10.  Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.

Authors:  Bhopal Mohapatra; Gulzar Ahmad; Scott Nadeau; Neha Zutshi; Wei An; Sarah Scheffe; Lin Dong; Dan Feng; Benjamin Goetz; Priyanka Arya; Tameka A Bailey; Nicholas Palermo; Gloria E O Borgstahl; Amarnath Natarajan; Srikumar M Raja; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Biochim Biophys Acta       Date:  2012-10-17
View more
  9 in total

1.  EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling.

Authors:  Eric C Tom; Insha Mushtaq; Bhopal C Mohapatra; Haitao Luan; Aaqib M Bhat; Neha Zutshi; Sukanya Chakraborty; Namista Islam; Priyanka Arya; Timothy A Bielecki; Fany M Iseka; Sohinee Bhattacharyya; Luke R Cypher; Benjamin T Goetz; Simarjeet K Negi; Matthew D Storck; Sandeep Rana; Angelika Barnekow; Pankaj K Singh; Guoguang Ying; Chittibabu Guda; Amarnath Natarajan; Vimla Band; Hamid Band
Journal:  Mol Cell Biol       Date:  2020-03-16       Impact factor: 4.272

2.  Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

Authors:  Michael A Rak; Jason Buehler; Sebastian Zeltzer; Justin Reitsma; Belen Molina; Scott Terhune; Felicia Goodrum
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

3.  CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface.

Authors:  Luke R Cypher; Timothy Alan Bielecki; Lu Huang; Wei An; Fany Iseka; Haitao Luan; Eric Tom; Matthew D Storck; Adam D Hoppe; Vimla Band; Hamid Band
Journal:  Cell Signal       Date:  2016-05-17       Impact factor: 4.315

4.  Mechanism of p38 MAPK-induced EGFR endocytosis and its crosstalk with ligand-induced pathways.

Authors:  Mireia Perez Verdaguer; Tian Zhang; Joao A Paulo; Steven Gygi; Simon C Watkins; Hiroaki Sakurai; Alexander Sorkin
Journal:  J Cell Biol       Date:  2021-05-25       Impact factor: 10.539

5.  E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.

Authors:  Syed Feroj Ahmed; Lori Buetow; Mads Gabrielsen; Sergio Lilla; Gary J Sibbet; David Sumpton; Sara Zanivan; Ann Hedley; William Clark; Danny T Huang
Journal:  Oncogene       Date:  2021-02-24       Impact factor: 9.867

6.  A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.

Authors:  Benjamin Goetz; Wei An; Bhopal Mohapatra; Neha Zutshi; Fany Iseka; Matthew D Storck; Jane Meza; Yuri Sheinin; Vimla Band; Hamid Band
Journal:  Oncotarget       Date:  2016-08-09

7.  Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment.

Authors:  Yiyao Cui; Ruiqin Hou; Xiaoshuo Lv; Feng Wang; Zhaoyan Yu; Yong Cui
Journal:  Front Oncol       Date:  2021-10-25       Impact factor: 6.244

8.  CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.

Authors:  Baocai Liu; Yu Su; Ting Li; Wanqiong Yuan; Xiaoning Mo; Henan Li; Qihua He; Dalong Ma; Wenling Han
Journal:  Oncotarget       Date:  2015-12-01

9.  Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors.

Authors:  Paramita Ray; Yee Sun Tan; Vishal Somnay; Ranjit Mehta; Merna Sitto; Aarif Ahsan; Shyam Nyati; John P Naughton; Alexander Bridges; Lili Zhao; Alnawaz Rehemtulla; Theodore S Lawrence; Dipankar Ray; Mukesh K Nyati
Journal:  Oncotarget       Date:  2016-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.